Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ventavis in pediatric pulmonary arterial hypertension
NCT00453414Phase 2Withdrawn
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2006
- Primary completion
- Oct 2006
- Countries
- 1
01
Overview
A Phase 2 trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Planned start Jul 2006; status: withdrawn.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00453414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453414.